FindTrial
Sign In

Study Of Dadimadya Ghritam In Childhood Iron deficiency Anemia

Clinical Evaluation Of Dadimadya Ghritam In Childhood Iron Deficiency Anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044153
Enrollment
30
Registered
2022-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency

Interventions

None listed

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 5 years to 10 years having signs & symptoms of Iron deficiency anemia

Exclusion criteria

Exclusion criteria: Age below 5 years & above 10 years

Design outcomes

Primary

MeasureTime frame
Clinical Evaluation Of Dadimadya Ghritam In Childhood Iron Deficiency Anemia Subjectively all signs and symptoms are given with grading depending upon their severity.Timepoint: 12 weeks—

Secondary

MeasureTime frame
Clinical evaluation of Dadimadya ghritam in childhood iron deficiency anemia Subjectively all signs and symptoms are given with grading depending upon their severity.Timepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Mandeep Kaur

Rishikul Campus, Haridwar, Uttrakhand

drdcschauhan@gmail.com9411175362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026